Back to discover
Disease

Death, Sudden

Late-stage therapeutic developmentEmerging research
MeSHDeath, Sudden
1
Publications
7
Clinical trials
2009
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

4 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
7
All trials
0
Active
5
Late-stage
6
Completed
Late-stage studies

Prognostic, Anti-arrhythmic, and Ventricular Remodeling Effects of High Dose Fish Oil in Patients With a Recent Myocardial Infarction

Phase 3 · Completed · Brigham and Women's Hospital

Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

Phase 3 · Completed · National Heart, Lung, and Blood Institute (NHLBI)

CSP #399 - The Effects of Antiarrhythmic Therapy in Maintaining Stability of Sinus Rhythm in Atrial Fibrillation

Phase 3 · Completed · US Department of Veterans Affairs

Cardiac Arrhythmia Suppression Trial (CAST)

Phase 3 · Completed · National Heart, Lung, and Blood Institute (NHLBI)

Multicenter Unsustained Tachycardia Trial (MUSTT)

Phase 3 · Completed · National Heart, Lung, and Blood Institute (NHLBI)
Recently completed

The Effects of Oral Proteolytic and Hydrolytic Enzymes and Flavonoids on Inflammatory Markers and Coagulation After Marathon Running

Phase 1 · Completed · Technical University of Munich

Prognostic, Anti-arrhythmic, and Ventricular Remodeling Effects of High Dose Fish Oil in Patients With a Recent Myocardial Infarction

Phase 3 · Completed · Brigham and Women's Hospital

Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

Phase 3 · Completed · National Heart, Lung, and Blood Institute (NHLBI)

CSP #399 - The Effects of Antiarrhythmic Therapy in Maintaining Stability of Sinus Rhythm in Atrial Fibrillation

Phase 3 · Completed · US Department of Veterans Affairs

Cardiac Arrhythmia Suppression Trial (CAST)

Phase 3 · Completed · National Heart, Lung, and Blood Institute (NHLBI)

Multicenter Unsustained Tachycardia Trial (MUSTT)

Phase 3 · Completed · National Heart, Lung, and Blood Institute (NHLBI)

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Leading journals1
  • Circulation1
Leading researchers5
  • Doerer JJ1
  • Haas TS1
  • Maron BJ1
  • Mueller FO1
  • Tierney DM1
Affiliations (unnormalised)1
  • Hypertrophic Cardiomyopathy Center1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.

Identifiers
MeSHDeath, Sudden
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.